Shares of Ormat Technologies leapt 10.3% to $103.88 in pre-market trading on November 4, hours before the geothermal energy company is set to report third-quarter results after the close. No confirmed news explains the spike, but the move speaks to a market bracing for another upside surprise from a company that has beaten earnings estimates in seven of its last eight quarters.
• A Pattern of Blowout Quarters Has Trained Investors to Buy Early. In the most recent report (Q2), Ormat posted $0.50 per share against expectations of $0.29 — a 72% surprise.
Q1 was even more dramatic: record revenue of $403.9 million, with adjusted EPS of $1.30 nearly doubling the $0.68 a year earlier and beating estimates by 43%.
Analysts' most recent models again suggest an upside lean, with an Earnings ESP — a measure of how the sharpest estimates compare to the consensus — of +29.4%. That track record alone can explain pre-market momentum.
• The Consensus Bar Is Low, But Revenue Growth Is Slowing. Wall Street expects just $0.34 per share on $246 million in revenue — a year-over-year decline of 17% on earnings and 1.5% on sales. That looks modest against full-year guidance of $1.11–$1.16 billion, or roughly 15% growth. The gap suggests Q3 may be a lighter quarter by design — the lumpy Product segment, which swung wildly on a one-time power-plant sale earlier this year, can shift hundreds of millions between quarters.
• Data-Center Deals Anchor the Long-Term Story. Ormat locked in a 15-year deal to supply up to 150 MW of geothermal power for Google's data centers via NV Energy , plus a 20-year, ~13 MW contract with data-center operator Switch.
The company is also piloting enhanced geothermal systems (EGS) — technology that borrows fracking techniques to build clean power plants closer to where customers need them — with drilling at the Desert Peak project with partner SLB planned for Q4 2026. Each hyperscaler contract could eventually reach 500 MW, per management.
• Valuation Already Reflects Optimism. At a trailing P/E of ~45x and a market cap of $5.65 billion , Ormat trades well above utility peers. JPMorgan recently cut its target to $98 with a Neutral rating; UBS downgraded to Neutral at $100.
The average analyst target sits at $127.62 , implying upside — but only if the EGS thesis delivers. Tonight's results, and tomorrow's conference call, will test whether the stock's pre-market vote of confidence was justified.